scholarly journals Correction to: Abnormal Cerebellar Volume in Patients with Remitted Major Depression with Persistent Cognitive Deficits

2021 ◽  
Author(s):  
Malte S. Depping ◽  
Mike M. Schmitgen ◽  
Claudia Bach ◽  
Lena Listunova ◽  
Johanna Kienzle ◽  
...  
2020 ◽  
Vol 19 (6) ◽  
pp. 762-770
Author(s):  
Malte S. Depping ◽  
Mike M. Schmitgen ◽  
Claudia Bach ◽  
Lena Listunova ◽  
Johanna Kienzle ◽  
...  

2013 ◽  
Vol 25 (6) ◽  
pp. 334-341 ◽  
Author(s):  
Tina Gooren ◽  
Peter Schlattmann ◽  
Peter Neu

ObjectiveEven though cognitive deficits are well recognised in schizophrenia and depression, direct comparisons between the disorders are scarce in literature. This study aims to assess specificity and degree of cognitive deficits in inpatients with acute schizophrenia and unipolar major depression.MethodsA neuropsychological test battery was administered to 76 schizophrenic patients, 102 patients with unipolar major depression and 85 healthy controls (HCs), assessing verbal learning [Rey Auditory Verbal Learning Test (RAVLT)], processing speed (Trail Making Test), verbal fluency and visual memory (Wechsler Memory Scale-Revised test).ResultsBoth patient groups were significantly impaired compared with HCs with regard to all test outcomes. The schizophrenia group (SG) performed significantly worse in the Wechsler Memory Scale and verbal fluency than the depression group (DG). The DG reached significantly lower scores than the SG in the RAVLT delayed recall subtest. No significant group difference between SG and DG was found for the Trail Making Test and the RAVLT direct recall trails.ConclusionOur results indicate that cognitive impairment is present in both disorders. Schizophrenic patients performed worse than patients with unipolar depression in only two of the administered tests. Differences in cognitive performance between the groups are not as general as often assumed. Therefore, during the acute phase of illness, a diagnostic classification on the grounds of the patients’ neurocognitive performance has to be done with caution.


Author(s):  
Malte S. Depping ◽  
Nadine D. Wolf ◽  
Nenad Vasic ◽  
Fabio Sambataro ◽  
Dusan Hirjak ◽  
...  

1993 ◽  
Vol 38 (10) ◽  
pp. 671-677 ◽  
Author(s):  
Isabelle Paquette

The study of psychiatric manifestations in dementia has long been overshadowed by the more classical manifestations of the disease, such as memory loss and other cognitive deficits. In recent years, however, psychiatric symptoms as part of the demential process have attracted interest and research has become more specific. Clinicians are faced with diagnostic, treatment and management difficulties related to affective or psychotic symptoms, which account for much distress and morbidity. Several studies indicate that the prevalence of psychiatric manifestations in clinical populations of patients suffering from dementia is high: 15% to 30% for hallucinations, 15% to 30% for delusions, ten percent to 20% for major depression and 40% to 50% for depressed mood. These figures tend to confirm the hypothesis that psychiatric features in dementia are neither infrequent nor atypical. Thus, researchers have sought to link psychotic or depressive symptomatology with several clinical characteristics of dementia, namely stage, severity, prognosis or cognitive dysfunction. Some recent studies involving extensive neuropsychological evaluations indicate that subgroups of patients can be defined according to psychiatric criteria, as well as cognitive or neurological criteria. Unfortunately, results are inconsistent. Some of the contradictions in the literature are related to poorly defined terms and symptoms, a lack of reliable operational criteria, absence of validation of instruments and scales and heterogeneity of the populations studied. Ambiguous syndromes, such as pseudodementia, while illustrative of certain clinical situations, have not been helpful in categorizing demented patients. The author suggests that research focused on specific and clearly defined psychiatric symptoms in dementia will better serve our comprehension of mixed syndromes.


Depression ◽  
1993 ◽  
Vol 1 (3) ◽  
pp. 156-158 ◽  
Author(s):  
P. Rodrigo Escalona ◽  
Bridget Early ◽  
William M. McDonald ◽  
P. Murali Doraiswamy ◽  
Sunjay A. Shah ◽  
...  

Author(s):  
Alexandria S. Coles ◽  
Yena Lee ◽  
Mehala Subramaniapillai ◽  
Roger S. McIntyre

2008 ◽  
Vol 14 (4) ◽  
pp. 552-561 ◽  
Author(s):  
JENNIFER UEKERMANN ◽  
MONA ABDEL-HAMID ◽  
CAROLINE LEHMKÄMPER ◽  
WOLFGANG VOLLMOELLER ◽  
IRENE DAUM

Major depression is associated with impairments of executive functions and affect perception deficits, both being linked to dysfunction of fronto-subcortical networks. So far, little is known about the relationship between cognitive and affective deficits in major depression. In the present investigation, affect perception and executive functions were assessed in 29 patients with a diagnosis of major depression (Dep) and 29 healthy controls (HC). Both groups were comparable on IQ, age, and gender distribution. Depressed patients showed deficits of perception of affective prosody, which were significantly related to inhibition, set shifting, and working memory. Our findings suggest a significant association between cognitive deficits and affect perception impairments in major depression, which may be of considerable clinical relevance and might be addressed in treatment approaches. Future studies are desirable to investigate the nature of the association in more detail. (JINS, 2008, 14, 552–561.)


2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
H.-J. Schewe ◽  
K. Vohs ◽  
R. Uebelhack

We compared horizontal saccadic eye movements in patients with dementia (n=18), and age-matched patients with major depression (n=18) or healthy controls (n=18). Cognitive functions were evaluated using Mini-Mental-State-Examination (MMSE) and ADAS-cog.Results:Saccadic latency and number of saccadic intrusions were significantly (p< 0.001) higher in patients with dementia relative to healthy controls and depressed patients. There were significant correlations between MMSE total score and latency (r = -0.78, p< 0.01) or number of saccadic intrusions (r = -0.80, p< 0.001) in the demential group. In addition, both saccadic parameters were significantly associated with ADAS-cog total score of patients with dementia, whereas the subscale “orientation” showed the strongest correlation with latency (r = 0.71, p< 0.01) and intrusions (r = 0.74, p< 0.01).There were no significant differences in saccadic eye movements between healthy controls and patients with major depression as a whole, or a subgroup of depressed patients with the worst cognitive performance (n=9).Conclusions:It seems that disturbances in horizontal saccadic eye movements in patients with dementia are related to the degree of cognitive deficits in these patients. On the other hand, the lack of alterations in horizontal saccadic eye movements in depressed patients despite poor cognitive performance indicates different mechanism.


2007 ◽  
Vol 14 (1) ◽  
pp. 55-62 ◽  
Author(s):  
J. UEKERMANN ◽  
S. CHANNON ◽  
C. LEHMKÄMPER ◽  
M. ABDEL-HAMID ◽  
W. VOLLMOELLER ◽  
...  

Major depression is associated with cognitive deficits including memory, executive functions, and affect perception, which have been linked to dysfunction of fronto-subcortical networks. However, little is known about social cognition on more complex socially relevant tasks, such as humor processing. In this investigation a computerized humor-processing task was administered to 27 patients with a diagnosis of major depression (Dep) and 27 healthy controls (HC). Theory of mind (mentalizing) and executive functions were also assessed. Both groups were similar in IQ, age, and gender. Depressed patients performed below the control group with respect to both affective and cognitive aspects of humor processing, and these were related to mentalizing and executive performance. Our findings suggest social cognition deficits in major depression. Ability to process humor and appreciate mentalistic perspectives may in turn influence social interactions and should be given consideration in therapeutic approaches to depression. (JINS, 2008,14, 55–62.)


2017 ◽  
Vol 51 (03) ◽  
pp. 100-104 ◽  
Author(s):  
Xian-Bin Li ◽  
Wei Zheng ◽  
Yu-Ping Ning ◽  
Dong-Bin Cai ◽  
Xin-Hu Yang ◽  
...  

Abstract Introduction The purpose of this study is to systematically review the efficacy and safety of adjunctive erythropoietin (EPO) in treating cognitive deficits associated with schizophrenia, bipolar disorder, and major depression based on randomized controlled trials (RCTs). Methods Two evaluators independently and systematically searched and selected studies, extracted data, and conducted quality assessment. Results Four RCTs with 144 patients (71 in the EPO group and 73 in the placebo group) met the study entry criteria. Adjunctive EPO could improve schizophrenia-related cognitive performance. In patients with bipolar disorder, EPO could also enhance sustained attention, recognition of happy faces, and speed of complex information processing across learning, attention, and executive function when compared with placebo. In addition, EPO could enhance verbal recall, recognition, and memory in patients with major depression. Discussion This preliminary study found that adjunctive EPO appears to be effective in treating cognitive deficits associated with schizophrenia, bipolar disorder, and major depression without major adverse effects observed. Further higher quality RCTs with larger samples are needed to confirm the findings. Review registration: CRD42017058094


Sign in / Sign up

Export Citation Format

Share Document